Hindustan Bio Sciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 3.89 million compared to INR 3.33 million a year ago. Revenue was INR 3.89 million compared to INR 3.33 million a year ago. Net income was INR 0.402 million compared to INR 0.119 million a year ago. Basic earnings per share from continuing operations was INR 0.04 compared to INR 0.01 a year ago. Diluted earnings per share from continuing operations was INR 0.04 compared to INR 0.01 a year ago. Basic earnings per share was INR 0.04 compared to INR 0.01 a year ago. Diluted earnings per share was INR 0.04 compared to INR 0.01 a year ago.
For the full year, sales was INR 10.29 million compared to INR 9.22 million a year ago. Revenue was INR 10.53 million compared to INR 9.22 million a year ago. Net income was INR 0.577 million compared to net loss of INR 0.405 million a year ago. Basic earnings per share from continuing operations was INR 0.06 compared to basic loss per share from continuing operations of INR 0.04 a year ago. Diluted earnings per share from continuing operations was INR 0.06 compared to diluted loss per share from continuing operations of INR 0.04 a year ago. Basic earnings per share was INR 0.06 compared to basic loss per share of INR 0.04 a year ago. Diluted earnings per share was INR 0.06 compared to diluted loss per share of INR 0.04 a year ago.